CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 125 enrolled
Drug / intervention
Decision Support Tool +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01721200
NCT01721200N/ACompleted
CompareCT.gov

"Learning About Biologics"

Geisinger Clinic·interventional·Posted Nov 5, 2012·Updated Feb 19, 2018

In Brief

A clinical study evaluating Decision Support Tool and Usual Care for Rheumatoid Arthritis. Completed, enrolled 125 participants across 1 site.

Detailed Summary

This study is a randomized controlled trial designed to examine the efficacy of an educational decision support tool for patients with rheumatoid arthritis who continue to have active disease despite use of traditional disease modifying drugs. The study will take place at Geisinger Medical Center in Danville, PA. Eligible subjects will be identified by the treating physician and those providing consent will be randomized to usual care versus use of the decision support tool.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRheumatoid Arthritis
CountriesUnited States
CollaboratorsYale University

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedNov 5, 2012
Enrollment StartNov 1, 2012
Primary CompletionFeb 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 13.7 years ago

Interventions

Decision Support Toolother

Educational decision support tool for patients with rheumatoid arthritis

Usual Careother

Subjects randomized to the Usual Care Group will receive their biologic drug teaching from the rheumatologist as part of their routine care.